NCT04159610: A trial that was reported late by Dr. August Wolff GmbH & Co. KG Arzneimittel
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04159610 |
|---|---|
| Title | A Randomized, Open-Label, Multiple Dose, Two-Period Crossover Study Evaluating Maximum Use 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% in Men and Women With Primary Axillary Hyperhidrosis |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 1, 2022 |
| Completion date | Feb. 1, 2023 |
| Required reporting date | Feb. 1, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Jan. 17, 2025 |
| Days late | 151 |